Gilead Sciences · 1 day ago
Director, Statistical Programming
San Francisco Bay Area
Full-time
Onsite
Director/Executive
$210K/yr - $272K/yr
8+ years expGilead Sciences is dedicated to creating a healthier world by tackling major health challenges. The Director of Statistical Programming is responsible for leading a multi-disciplinary team in the development and management of statistical programming tools and solutions that support clinical analysis and reporting.
BiopharmaBiotechnologyHealth CareManufacturingPharmaceutical
Responsibilities
Lead, mentor, and develop a team of SAS macro programmers, data engineers, and application developers (including Linux scripting, Python console, and web applications) to deliver high-quality statistical programming solutions for clinical trials and regulatory submissions
Set clear goals, conduct performance assessments, and foster professional growth and continuous learning within the team
Oversee the design, development, validation, and maintenance of SAS macros, scripts, and applications supporting clinical data analysis, reporting, and regulatory deliverables (e.g., SDTM, ADaM datasets, TLFs)
Ensure programming infrastructure is robust, scalable, and compliant with regulatory standards (e.g., FDA 21 CFR Part 11, GxP), and supports reproducibility and audit readiness
Promote automation and standardization of programming workflows to improve efficiency and consistency across studies
Accountable for the timely and quality completion of all programming deliverables across assigned projects and studies, including resource allocation and prioritization
Manage project timelines, budgets, and external vendor relationships as needed
Collaborate with Biostatistics, Clinical Data Management, Regulatory Affairs, and IT to define programming requirements, align on analysis/reporting deliverables, and ensure data integrity
Represent the statistical programming function in cross-functional meetings and strategic initiatives
Lead the development and implementation of programming standards, best practices, and innovative solutions (including cloud-based platforms, AI/ML, and automation pipelines) to enhance efficiency and quality
Evaluate and integrate emerging technologies into statistical programming workflows
Ensure all programming activities adhere to SOPs, regulatory requirements, and internal quality standards; maintain audit readiness and documentation for all deliverables
Oversee code quality, version control, and documentation governance frameworks
Provide technical guidance and training on advanced programming techniques, tools, and industry trends to team members and stakeholders
Act as a key point of contact for external vendors and partners, ensuring alignment on programming standards and deliverables
Qualification
Required
PhD / PharmD and 8 years of experience
OR
Master's and 10 years of experience
OR
Bachelor's and 12 years of experience
Preferred
Education: BS/MS/PhD in Biostatistics, Computer Science, or related field; advanced degree preferred
Technical Skills: Expert in SAS Macros and strong proficiency in Python; working knowledge of R and Linux scripting; familiarity with AWS Cloud
Core Competencies: Strategic thinking, cross-functional influence, compliance mindset, talent development, user-centric engineering
Benefits
Discretionary annual bonus
Discretionary stock-based long-term incentives (eligibility may vary based on role)
Paid time off
Company-sponsored medical, dental, vision, and life insurance plans
Company
Gilead Sciences
Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.
10001+ employees
H1B Sponsorship
Gilead Sciences has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (269)
2024 (241)
2023 (222)
2022 (208)
2021 (235)
2020 (187)
Funding
Current Stage
Public CompanyTotal Funding
$4.41BKey Investors
Abingworth
2024-11-13Post Ipo Debt· $3.5M
2024-02-29Post Ipo Equity· $210M
2023-09-07Post Ipo Debt· $2B
Leadership Team
Keeley Wettan
Senior Vice President, Legal
Patrick Loerch
Senior Vice President, Clinical Data Science
Recent News
2026-01-09
2026-01-08
2026-01-07
Company data provided by crunchbase